Skip to main content
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. — Investor Relations & Filings

Ticker · ENVB ISIN · US02362F3029 US Professional, scientific and technical activities
Open in API
Filings indexed 1,028 across all filing types
Latest filing 2021-08-13 Interim / Quarterly Rep…
Country US United States of America
Listing US ENVB

About Enveric Biosciences, Inc.

https://www.enveric.com/

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2021
Interim / Quarterly Report Q2 2021
2021-08-13 English
Regulatory Filings 2021
Regulatory Filings
2021-08-09 English
Proxy Solicitation & Information Statement 2021
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy statement/prospectus filed pursuant to Rule 424(b)(3) related to a proposed amalgamation transaction between Enveric Biosciences, Inc. and MagicMed Industries Inc. It includes detailed information about the proposed transaction, voting matters for the annual meeting of stockholders, election of directors, approval of share issuance, advisory vote on executive compensation, and ratification of auditors. The document is clearly a solicitation of proxies for the annual meeting and contains detailed information to inform shareholders about the proposals to be voted on. It is not a full annual report, earnings release, or other financial report, but rather a proxy solicitation document with a prospectus component related to a merger/amalgamation transaction. Therefore, the most appropriate classification is Proxy Solicitation & Information Statement (PSI).
2021-08-06 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter from Enveric Biosciences, Inc. addressed to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-4. It references the Registration Statement filed on June 22, 2021, and requests the SEC to make it effective on August 6, 2021. The content is a formal regulatory communication related to a securities registration process, specifically a request for acceleration under SEC rules. The document is short (1483 characters) and does not contain financial statements, detailed financial data, or report content. It is not the Registration Statement itself but a correspondence related to it. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-08-04 English
Merger & Acquisition 2021
Merger & Acquisition Classification · 100% confidence The document is a Form S-4/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It relates to a proposed amalgamation (merger) between Enveric Biosciences, Inc. and MagicMed Industries Inc. The text includes detailed information about the merger agreement, stockholder meetings, voting proposals, and issuance of shares in connection with the merger. It also contains a preliminary proxy statement/prospectus, which is used to solicit shareholder votes for the merger and related matters. The document is not a simple announcement but a comprehensive filing related to a merger transaction, including proxy solicitation materials. Given the detailed merger-related content and the proxy solicitation nature, the appropriate classification is Merger & Acquisition (MA).
2021-08-04 English
Regulatory Filings 2021
Regulatory Filings
2021-07-12 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.